The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sette, A.
Right arrow Articles by Grey, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sette, A.
Right arrow Articles by Grey, H. M.

The Journal of Immunology, Vol 148, Issue 3 844-851, Copyright © 1992 by American Association of Immunologists


ARTICLES

Effect of pH on MHC class II-peptide interactions

A Sette, S Southwood, D O'Sullivan, FC Gaeta, J Sidney and HM Grey
Cytel, San Diego, CA 92121.

The effect of pH on class II-peptide interactions has been analyzed using several mouse (IAd, IAk, IEd, IEk) and human (DR1, DR5, DR7) MHC specificities, and eight different class II-restricted determinants. In direct binding assays, acidic conditions led to increased binding capacity for many class II-peptide combinations. IE molecules seemed to bind optimally around pH 4.5, whereas IA molecules displayed binding optima in the 5.5 to 6.5 range. In contrast, the DR molecules studied were, in most cases, affected only marginally by pH changes in the 4.5 to 7.0 range. Despite these apparent isotype-specific trends, no general rule could be formulated, because even for the same class II molecules, the binding capacity could be increased for many peptides when the binding was performed under acidic conditions, was unaffected for some, and even decreased for others. The mechanisms responsible for this complex behavior were analyzed in more detail by kinetic and equilibrium analysis of three different class II-peptide combinations (IAd/OVA 323-339, IAk/HEL 46-61, and DR1/HA 307-319). It was found that acidic pH conditions could affect both on and off rates for class II- peptide complexes. Depending on the net balance of these effects, either increases, decreases, or no effect on overall affinities at equilibrium were detected. In the case of IAd/OVA 323-339, it was also found that acidic conditions influenced the binding capacity of class II molecules by increasing the fraction of sites available for peptide binding, presumably by favoring dissociation of endogenously bound, acid-sensitive peptides.


This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Martinez-Soria, N. Ibnou-Zekri, M. Iwamoto, M.-L. Santiago-Raber, S. Kikuchi, M. Kosco-Vilbois, and S. Izui
Epitope-Dependent Inhibition of T Cell Activation by the Ea Transgene: An Explanation for Transgene-Mediated Protection from Murine Lupus
J. Immunol., August 15, 2004; 173(4): 2842 - 2848.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. J. Prakken, R. Samodal, T. D. Le, F. Giannoni, G. P. Yung, J. Scavulli, D. Amox, S. Roord, I. de Kleer, D. Bonnin, et al.
Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis
PNAS, March 23, 2004; 101(12): 4228 - 4233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Saito, A. Sarai, M. Oda, T. Azuma, and H. Kozono
Thermodynamic Analysis of the Increased Stability of Major Histocompatibility Complex Class II Molecule I-Ek Complexed with an Antigenic Peptide at an Acidic pH
J. Biol. Chem., April 18, 2003; 278(17): 14732 - 14738.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. C. Wilson, B. Palmer, S. Southwood, J. Sidney, Y. Higashimoto, E. Appella, R. Chesnut, A. Sette, and B. D. Livingston
Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes
J. Virol., May 1, 2001; 75(9): 4195 - 4207.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
N. Pimtanothai, M. Parra, A. H. Johnson, C. S. David, and C. Katovich Hurley
Assessing the Binding of Four Plasmodium falciparum T Helper Cell Epitopes to HLA-DQ and Induction of T-Cell Responses in HLA-DQ Transgenic Mice
Infect. Immun., March 1, 2000; 68(3): 1366 - 1373.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. D. Moudgil, S. Southwood, A. Ametani, K. Kim, A. Sette, and E. E. Sercarz
The Self-Directed T Cell Repertoire Against Mouse Lysozyme Reflects the Influence of the Hierarchy of Its Own Determinants and Can Be Engaged by a Foreign Lysozyme
J. Immunol., October 15, 1999; 163(8): 4232 - 4237.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
R. Wang, Y. Wang-Zhu, C. R. Gabaglia, K. Kimachi, and H. M. Grey
The Stimulation of Low-Affinity, Nontolerized Clones by Heteroclitic Antigen Analogues Causes the Breaking of Tolerance Established to an Immunodominant T Cell Epitope
J. Exp. Med., October 4, 1999; 190(7): 983 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Mamula, R. J. Gee, J. I. Elliott, A. Sette, S. Southwood, P.-J. Jones, and P. R. Blier
Isoaspartyl Post-translational Modification Triggers Autoimmune Responses to Self-proteins
J. Biol. Chem., August 6, 1999; 274(32): 22321 - 22327.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. R. Rogers and M. Croft
Peptide Dose, Affinity, and Time of Differentiation Can Contribute to the Th1/Th2 Cytokine Balance
J. Immunol., August 1, 1999; 163(3): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Natarajan, M. Assadi, and S. Sadegh-Nasseri
Stable Peptide Binding to MHC Class II Molecule Is Rapid and Is Determined by a Receptive Conformation Shaped by Prior Association with Low Affinity Peptides
J. Immunol., April 1, 1999; 162(7): 4030 - 4036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. I. Pearson, A. M. Gautam, I. C. Rulifson, R. S. Liblau, and H. O. McDevitt
A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11
PNAS, January 5, 1999; 96(1): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Zugel, R. Wang, G. Shih, A. Sette, J. Alexander, and H. M. Grey
Termination of Peripheral Tolerance to a T Cell Epitope by Heteroclitic Antigen Analogues
J. Immunol., August 15, 1998; 161(4): 1705 - 1709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. G. Phelps, V. L. Jones, M. Coughlan, A. N. Turner, and A. J. Rees
Presentation of the Goodpasture Autoantigen to CD4 T Cells Is Influenced More by Processing Constraints Than by HLA Class II Peptide Binding Preferences
J. Biol. Chem., May 8, 1998; 273(19): 11440 - 11447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Fridkis-Hareli and J. L. Strominger
Promiscuous Binding of Synthetic Copolymer 1 to Purified HLA-DR Molecules
J. Immunol., May 1, 1998; 160(9): 4386 - 4397.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. R. Rogers, H. M. Grey, and M. Croft
Modulation of Naive CD4 T Cell Activation with Altered Peptide Ligands: The Nature of the Peptide and Presentation in the Context of Costimulation Are Critical for a Sustained Response
J. Immunol., April 15, 1998; 160(8): 3698 - 3704.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Southwood, J. Sidney, A. Kondo, M.-F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
J. Immunol., April 1, 1998; 160(7): 3363 - 3373.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Gapin, Y. Bravo de Alba, A. Casrouge, J. P. Cabaniols, P. Kourilsky, and J. Kanellopoulos
Antigen Presentation by Dendritic Cells Focuses T Cell Responses Against Immunodominant Peptides: Studies in the Hen Egg-White Lysozyme (HEL) Model1
J. Immunol., February 15, 1998; 160(4): 1555 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Reich, J. D. Altman, J. J. Boniface, D. S. Lyons, H. Kozono, G. Ogg, C. Morgan, and M. M. Davis
Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: Comparison to class I proteins
PNAS, March 18, 1997; 94(6): 2495 - 2500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Roucard, F. Garban, N. A. Mooney, D. J. Charron, and M. L. Ericson
Conformation of Human Leukocyte Antigen Class II Molecules. EVIDENCE FOR SUPERDIMERS AND EMPTY MOLECULES ON HUMAN ANTIGEN PRESENTING CELLS
J. Biol. Chem., June 14, 1996; 271(24): 13993 - 14000.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Nag, S. Arimilli, P. V. Mukku, and I. Astafieva
Functionally Active Recombinant alpha and beta Chain-Peptide Complexes of Human Major Histocompatibility Class II Molecules
J. Biol. Chem., April 26, 1996; 271(17): 10413 - 10418.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H Bodmer, S Viville, C Benoist, and D Mathis
Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain
Science, March 4, 1994; 263(5151): 1284 - 1286.
[Abstract] [PDF]


Home page
ScienceHome page
A Sette, S Ceman, R. Kubo, K Sakaguchi, E Appella, D. Hunt, T. Davis, H Michel, J Shabanowitz, R Rudersdorf, et al.
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant
Science, December 11, 1992; 258(5089): 1801 - 1804.
[Abstract] [PDF]


Home page
ScienceHome page
D. Hunt, H Michel, T. Dickinson, J Shabanowitz, A. Cox, K Sakaguchi, E Appella, H. Grey, and A Sette
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad
Science, June 26, 1992; 256(5065): 1817 - 1820.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.